% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Kagermeier:270812,
author = {Kagermeier, Theresa and Hauser, Stefan and Sarieva, Kseniia
and Laugwitz, Lucia and Groeschel, Samuel and Janzarik,
Wibke G and Yentür, Zeynep and Becker, Katharina and
Schöls, Ludger and Kragelöh-Mann, Ingeborg and Mayer,
Simone},
title = {{H}uman organoid model of pontocerebellar hypoplasia 2a
recapitulates brain region-specific size differences.},
journal = {Disease models $\&$ mechanisms},
volume = {17},
number = {7},
issn = {1754-8403},
address = {Cambridge},
publisher = {Company of Biologists Limited},
reportid = {DZNE-2024-00902},
pages = {dmm050740},
year = {2024},
abstract = {Pontocerebellar hypoplasia type 2a (PCH2a) is an
ultra-rare, autosomal recessive pediatric disorder with
limited treatment options. Its anatomical hallmark is
hypoplasia of the cerebellum and pons accompanied by
progressive microcephaly. A homozygous founder variant in
TSEN54, which encodes a tRNA splicing endonuclease (TSEN)
complex subunit, is causal. The pathological mechanism of
PCH2a remains unknown due to the lack of a model system.
Therefore, we developed human models of PCH2a using
regionalized neural organoids. We generated induced
pluripotent stem cell (iPSC) lines from three males with
genetically confirmed PCH2a and subsequently differentiated
cerebellar and neocortical organoids. Mirroring clinical
neuroimaging findings, PCH2a cerebellar organoids were
reduced in size compared to controls starting early in
differentiation. Neocortical PCH2a organoids demonstrated
milder growth deficits. Although PCH2a cerebellar organoids
did not upregulate apoptosis, their stem cell zones showed
altered proliferation kinetics, with increased proliferation
at day 30 and reduced proliferation at day 50 compared to
controls. In summary, we generated a human model of PCH2a,
providing the foundation for deciphering brain
region-specific disease mechanisms. Our first analyses
suggest a neurodevelopmental aspect of PCH2a.},
keywords = {Humans / Organoids: pathology / Induced Pluripotent Stem
Cells: metabolism / Induced Pluripotent Stem Cells:
pathology / Male / Brain: pathology / Cell Differentiation /
Cerebellum: abnormalities / Cerebellum: pathology /
Olivopontocerebellar Atrophies: pathology /
Olivopontocerebellar Atrophies: genetics / Cell
Proliferation / Organ Size / Models, Biological / Apoptosis
/ Cerebellar Diseases / Apoptosis (Other) / Cerebellum
(Other) / Differentiation (Other) / Organoid (Other) / PCH2a
(Other) / Rare disease (Other)},
cin = {AG Schöls / AG Hauser},
ddc = {570},
cid = {I:(DE-2719)5000005 / I:(DE-2719)1210016},
pnm = {353 - Clinical and Health Care Research (POF4-353) / 352 -
Disease Mechanisms (POF4-352)},
pid = {G:(DE-HGF)POF4-353 / G:(DE-HGF)POF4-352},
typ = {PUB:(DE-HGF)16},
pmc = {pmc:PMC11552497},
pubmed = {pmid:39034883},
doi = {10.1242/dmm.050740},
url = {https://pub.dzne.de/record/270812},
}